Cullinan Therapeutics, Inc. (CGEM)
(Real Time Quote from BATS)
$21.84 USD
-0.70 (-3.11%)
Updated Jun 4, 2024 09:30 AM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.73 |
EPS Last Quarter | -0.86 |
Last EPS Surprise | 4.44% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.02 |
Next Year | -3.07 |
EPS (TTM) | -3.13 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 15.00M | 50.68M |
# of Estimates | NA | NA | 1 | 2 |
High Estimate | NA | NA | 15.00M | 53.64M |
Low Estimate | NA | NA | 15.00M | 47.71M |
Year ago Sales | 0.00M | 0.00M | NA | 15.00M |
Year over Year Growth Est. | NA | NA | NA | 237.83% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.73 | -0.74 | -3.02 | -3.07 |
# of Estimates | 7 | 6 | 7 | 7 |
Most Recent Consensus | -0.74 | -0.73 | -3.11 | -2.75 |
High Estimate | -0.62 | -0.68 | -2.69 | -2.23 |
Low Estimate | -0.89 | -0.84 | -3.35 | -4.21 |
Year ago EPS | -0.82 | -0.91 | -3.69 | -3.02 |
Year over Year Growth Est. | 10.98% | 18.68% | 18.16% | -1.71% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 4 | 3 | 4 | 4 |
Up Last 60 Days | 4 | 3 | 4 | 4 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 2 | 3 | 3 | 2 |
Down Last 60 Days | 0 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.73 | -0.74 | -3.02 | -3.07 |
7 Days Ago | -0.73 | -0.74 | -3.02 | -3.07 |
30 Days Ago | -0.79 | -0.75 | -3.23 | -3.14 |
60 Days Ago | -0.87 | -0.88 | -3.55 | -3.37 |
90 Days Ago | -0.88 | -0.91 | -3.84 | -3.71 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.73 | -0.74 | -3.02 | -2.89 |
Zacks Consensus Estimate | -0.73 | -0.74 | -3.02 | -3.07 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 5.82% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.86 | -0.54 | -0.91 | -0.82 | NA |
Estimate | -0.90 | -0.96 | -0.91 | -0.99 | NA |
Difference | 0.04 | 0.42 | 0.00 | 0.17 | 0.16 |
Surprise | 4.44% | 43.75% | 0.00% | 17.17% | 16.34% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more